Skip to content
PubMed This is a summary of 34 peer-reviewed journal articles Updated
Endocrinology · TRMT10A-Related Disorder

TRMT10A-Related Disorder: A Patient Guide

At a Glance

TRMT10A-related disorder is a rare inherited condition that can affect head growth, development, height, and blood sugar. Diabetes often begins in the preteen years or early adulthood rather than at birth, so ongoing developmental and blood-sugar monitoring is important.

TRMT10A-related disorder is an exceptionally rare genetic condition that primarily affects three areas of a person’s health: the way the brain develops, how the body grows, and how the pancreas regulates blood sugar. Because this condition is autosomal recessive, a person only develops it if they inherit a non-working copy of the TRMT10A gene from both parents, who are usually healthy carriers. This genetic change interferes with the cell’s ability to protect and maintain specific tissues, leading to a unique combination of symptoms that doctors often refer to as primary microcephaly-mild intellectual disability-young-onset diabetes syndrome [1][2]. This guide is intended to help parents, caregivers, and affected individuals who are managing their own care understand and navigate this condition.

In the brain and body, this disorder typically shows itself early through microcephaly (a head size smaller than expected) and developmental delays. Most children reach milestones like walking and talking later than their peers and may experience mild intellectual disability. However, based on the limited number of reported individuals, progressive neurodegeneration or consistent regression has not been a prominent reported pattern; individuals typically continue to gain new skills and learn at their own pace. Any loss of acquired skills warrants prompt medical evaluation. While some individuals may also develop epilepsy (seizures), these neurological features are often the focus of early intervention and support through therapies and specialized education [3][4].

The metabolic and growth aspects of the disorder follow a much more variable timeline, often emerging later in childhood or even early adulthood. Many individuals experience short stature, which can sometimes be linked to a lack of growth hormone. Perhaps most uniquely, the young-onset diabetes associated with this condition is not typically present at birth. Instead, it can appear anytime from the pre-teen years into the early 20s. This means that even if a child’s or young adult’s blood sugar is currently healthy, lifelong monitoring is a standard part of their care, as the timing and severity of these metabolic changes can vary significantly from one person to another [5][6].

Living with a TRMT10A diagnosis means navigating a complex and often unpredictable path, but it also means having a clear roadmap for what to monitor. By partnering with a team of specialists—including pediatric or adult endocrinologists and neurologists—individuals and parents can proactively manage health and provide the targeted support needed. While the rarity of the condition can feel overwhelming, understanding the underlying biology allows families and medical teams to shift from searching for answers to focusing on the long-term well-being and growth of the individual [2][7].

Common questions in this guide

What is TRMT10A-related disorder?
TRMT10A-related disorder is a rare inherited condition caused when a person receives a non-working copy of the TRMT10A gene from each parent. It can affect brain development and learning, growth, and the pancreas’s regulation of blood sugar.
What developmental and physical features can TRMT10A-related disorder cause?
Common features include a smaller-than-expected head size, called microcephaly, delayed walking or talking, and mild intellectual disability. Some people also have seizures, short stature, or growth hormone deficiency.
When does diabetes usually develop with TRMT10A-related disorder?
The diabetes linked with TRMT10A-related disorder is usually not present at birth. It may develop anytime from the preteen years through the early 20s, so regular blood-sugar monitoring remains important even when current results are normal.
Does TRMT10A-related disorder cause loss of skills over time?
In the limited number of people reported, progressive brain deterioration or consistent loss of skills has not been a prominent pattern. Most individuals continue to learn and gain skills at their own pace, but any loss of an acquired skill should be evaluated promptly by a healthcare professional.
Which specialists and supports may help manage TRMT10A-related disorder?
Care may involve a pediatric or adult endocrinologist and a neurologist, with coordination among the specialists. Early intervention, developmental therapies, and specialized education can support learning, development, and day-to-day needs.
How is TRMT10A-related disorder inherited?
It follows an autosomal recessive pattern, meaning a person generally must inherit a non-working TRMT10A copy from both parents. The parents are often healthy carriers because they have one working copy and one non-working copy.

Get notified when new evidence is published on Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (7)
  1. 1

    Expanding the Phenotype of TRMT10A Mutations: Case Report and a Review of the Existing Cases

    Şıklar Z, Kontbay T, Colclough K, et al.

    Journal of clinical research in pediatric endocrinology 2023; (15(1)):90-96 doi:10.4274/jcrpe.galenos.2021.2021.0110.

    PMID: 34541035
  2. 2

    TRMT10A-Related Neurodevelopmental Disorder Without Metabolic Findings.

    Ülker Üstebay D, Aksu Şahin İ, Üstebay S, et al.

    Human mutation 2026; (2026()):8058409 doi:10.1155/humu/8058409.

    PMID: 42181738
  3. 3

    tRNA methyltransferase homologue gene TRMT10A mutation in young adult-onset diabetes with intellectual disability, microcephaly and epilepsy.

    Yew TW, McCreight L, Colclough K, et al.

    Diabetic medicine : a journal of the British Diabetic Association 2016; (33(9)):e21-5 doi:10.1111/dme.13024.

    PMID: 26526202
  4. 4

    Case Report: Compound heterozygous nonsense mutations in TRMT10A are associated with microcephaly, delayed development, and periventricular white matter hyperintensities.

    Narayanan M, Ramsey K, Grebe T, et al.

    F1000Research 2015; (4()):912 doi:10.12688/f1000research.7106.1.

    PMID: 26535115
  5. 5

    tRNA methyltransferase 10 homologue A (TRMT10A) mutation in a Chinese patient with diabetes, insulin resistance, intellectual deficiency and microcephaly.

    Lin H, Zhou X, Chen X, et al.

    BMJ open diabetes research & care 2020; (8(1)) doi:10.1136/bmjdrc-2020-001601.

    PMID: 33067246
  6. 6

    Homozygous deletion of TRMT10A as part of a contiguous gene deletion in a syndrome of failure to thrive, delayed puberty, intellectual disability and diabetes mellitus.

    Zung A, Kori M, Burundukov E, et al.

    American journal of medical genetics. Part A 2015; (167A(12)):3167-73 doi:10.1002/ajmg.a.37341.

    PMID: 26297882
  7. 7

    Discovery of a TRMT10A mutation in a case of atypical diabetes: Case report.

    Samhani C, Guerci B, Larose C

    Diabetes & metabolism 2024; (50(6)):101572 doi:10.1016/j.diabet.2024.101572.

    PMID: 39243962

This TRMT10A-related disorder page is for informational purposes only and does not constitute medical advice. An endocrinologist, neurologist, and other members of the healthcare team can tailor developmental and blood-sugar monitoring to the individual.